Skip to content
Breast-cancer — Research — Materials — Engineering — Medicine — Science — Medical-conditions — health-and-wellness — Cance — Graduate

Device for Spreading Cancer Cells within the Body

Researchers at MIT create a miniature fluid system to observe the invasion of cancer cells into particular organs.

,   and  Administrator
4 min read
Researchers at MIT develop a miniature fluidic system to investigate cancer cell infiltration into...
Researchers at MIT develop a miniature fluidic system to investigate cancer cell infiltration into particular organs.

Device for Spreading Cancer Cells within the Body

Invading Bone: The Hidden Battle Against Breast Cancer

Cancer cells gone rogue, traveling through the bloodstream, seeking refuge in distant organs. It's a frightening process known as metastasis that afflicts many patients with advanced breast cancer. More than two-thirds of these patients experience metastasis to the bones, a painful and potentially debilitating development. Scientists are racing to unravel the mystery behind this unwelcome guest, particularly why certain breast cancers gravitate towards particular organs, like bone, liver, and lungs.

A team of researchers from MIT, Italy, and South Korea have engineered a microfluidic platform that simulates the dissemination of breast cancer cells into a bone-like environment. The size of a dime, this revolutionary chip features several channels lined with endothelial cells - akin to blood vessels - and bone-like cells. Breast cancer cells were injected into the simulated blood vessel, and the results were astonishing.

Twice as many cancer cells made their way through the vessel wall and into the bone-like environment compared to when they were introduced to a simple collagen-gel matrix. In just five days, cell clusters comprising up to 60 cells had formed. "You can see how rapidly they are growing," says Jessie Jeon, a graduate student in mechanical engineering. "If we had gone longer, [the size of the clusters] would have been overwhelming."

Two proteins seem to play a street-level role in facilitating this invasion: CXCL5, a protein ligand secreted by bone cells, and CXCR2, a receptor protein on the surface of cancer cells that binds to CXCL5. Preliminary findings suggest that targeting these proteins could help curb the spread of cancer.

This research promises to pave the way for novel drug tests and insights into cancer's invasion of other organs. "Currently, we don't understand why certain cancers preferentially metastasize to specific organs," says Roger Kamm, the Cecil and Ida Green Distinguished Professor of Mechanical and Biological Engineering at MIT. "We can use our model system both to understand this selectivity, and also to screen for drugs that might prevent it."

The journey of cancer metastasis is a complex dance of survival, evasion, and invasion. At first, the cancer cells travel through the circulatory system, latching onto the inner lining of a blood vessel and forcing their way through a process known as extravasation. The newly formed microfluidic platform sheds light on this initial phase, serving as a springboard for exploring the subsequent invasion of specific organs like bone.

"The beauty of this system lies in its simplicity and elegance," says Muhammad Zaman, an associate professor of biological engineering at Boston University. "I believe that this microfluidic system will be easy to scale to study processes that are important yet have been too difficult to quantify."

The team plans to investigate breast cancer metastasis in other organs, such as muscle, an organ not typically prone to cancer spread. In the future, this platform may prove invaluable for personalized medicine, tailoring treatment plans to a patient's unique cancer profile.

Chemokine Shenanigans: A Twist in the Metastatic Tale

The interaction between CXCL5 and CXCR2 appears to play a significant role in the metastasis of breast cancer cells, particularly in environments where CXCL5 is expressed. While the specific details about the influence of CXCL5 and CXCR2 on bone metastasis remain scant, this pairing seems to help cancer cells spread and grow.

blockquote-1

  1. CXCL5 and CXCR2: A Deadly Duo
  2. CXCL5 is a ligand that binds with the CXCR2 receptor. This bond promotes tumor growth and metastasis by facilitating the migration and invasion of cancer cells[1]. In the case of triple-negative breast cancer, suppressing the IL-8/CXCR2 signaling axis - which involves structurally similar ligands like CXCL5 - has been shown to curb tumor growth and metastasis[1]. Inhibiting the CXCL5/CXCR2 interaction could, therefore, be an effective strategy for stunting metastasis.
  3. Luring Cancer Cells: A Bone's Perspective
  4. While data specific to the CXCL5/CXCR2 axis in bone metastasis is limited, another chemokine axis, CXCR4-CXCL12, is known to play a crucial role in the formation of pre-metastatic niches in bone marrow and lymph nodes[4]. This suggests that chemokine receptors like CXCR2 could similarly influence metastatic processes in bone by creating a welcoming environment for cancer cells.
  5. Future Research Directions
  6. Moving forward, researchers should focus on investigating the precise impact of the CXCL5/CXCR2 axis on metastasis to the bone in breast cancer. This could include studying the expression levels of CXCL5 and CXCR2 in bone metastases and examining the effects of inhibiting this axis on bone-specific metastasis.
  7. Investigating the molecular mechanisms underlying the CXCL5/CXCR2 axis could lead to the development of novel therapeutic strategies for targeting breast cancer metastasis to bones.
  8. By elucidating the role of these proteins in the metastatic process, researchers can gain valuable insights into the biological basis of breast cancer progression and sleuth effective treatments that efficiently combat the disease.
  9. Scientific journals and medical press publications should highlight the significance of the CXCL5/CXCR2 axis in breast cancer research, as the understanding of its impact on metastasis can propel the evolution of medical-conditions treatments and therapies-and-treatments.
  10. As graduates in engineering, medicine, and science continue to delve into the mysteries of the CXCL5/CXCR2 axis, they can pave the way for promising medical advancements in health-and-wellness, including cancer therapies and solutions intended to address breast cancer and other metastatic diseases.
  11. Research on the CXCL5/CXCR2 axis should expand to other organs beyond bone, to gain a comprehensive understanding of its influence on diverse medical-conditions and to uncover new avenues for targeted cancer treatments.
  12. In the arena of personalized medicine, understanding the role of the CXCL5/CXCR2 axis in breast cancer metastasis could provide clinicians with a potent tool for tailoring health-and-wellness approaches to the unique needs of their patients.

Read also:

    Related

    Latest